News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
9,885 Results
Type
Article (346)
Company Profile (1)
Press Release (9538)
Section
Business (2764)
Deals (436)
Drug Delivery (1)
Drug Development (699)
FDA (313)
Job Trends (236)
News (4264)
Policy (374)
Tag
Academia (19)
Alliances (827)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (19)
Approvals (311)
Artificial intelligence (6)
Bankruptcy (4)
Best Places to Work (232)
Breast cancer (31)
Cancer (88)
Cell therapy (2)
Clinical research (543)
Collaboration (16)
Compensation (5)
Complete response letters (2)
COVID-19 (40)
C-suite (4)
Data (34)
Diagnostics (1043)
Drug discovery (3)
Earnings (1183)
Events (1605)
Executive appointments (7)
FDA (344)
Funding (14)
Gene therapy (2)
GLP-1 (7)
Government (43)
Healthcare (218)
Infectious disease (41)
Intellectual property (2)
IPO (213)
Job creations (17)
Layoffs (4)
Legal (45)
Lung cancer (23)
Lymphoma (4)
Manufacturing (3)
Medical device (214)
Medtech (214)
Mergers & acquisitions (228)
Metabolic disorders (2)
Neuroscience (45)
NextGen: Class of 2025 (53)
Non-profit (30)
Northern California (35)
Ovarian cancer (5)
People (694)
Phase I (189)
Phase II (224)
Phase III (204)
Pipeline (9)
Podcasts (2)
Postmarket research (17)
Preclinical (72)
Prostate cancer (5)
Radiopharmaceuticals (4)
Rare diseases (6)
Real estate (32)
Regulatory (328)
Research institute (36)
Series A (2)
Series B (2)
Southern California (41)
Startups (47)
United States (372)
Date
Last 7 days (9)
Last 30 days (43)
Last 365 days (762)
2025 (94)
2024 (775)
2023 (839)
2022 (950)
2021 (1052)
2020 (960)
2019 (574)
2018 (427)
2017 (576)
2016 (517)
2015 (649)
2014 (433)
2013 (364)
2012 (302)
2011 (284)
2010 (232)
Location
Africa (3)
Arizona (8)
Asia (546)
Australia (101)
California (89)
Canada (29)
China (2)
Colorado (8)
Connecticut (23)
Delaware (7)
Europe (1143)
Florida (5)
Illinois (3)
Japan (12)
Maine (4)
Maryland (11)
Massachusetts (46)
Michigan (6)
Minnesota (8)
Montana (2)
New Jersey (29)
New Mexico (7)
New York (18)
North Carolina (10)
Northern California (35)
Pennsylvania (11)
South America (4)
Southern California (41)
Tennessee (13)
Texas (30)
Utah (16)
Virginia (5)
Washington State (5)
Wisconsin (6)
9,885 Results for "dcn dx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
FDA Grants EUA to Wondfo’s WELLlife™ COVID-19/Influenza A&B Test Supported by DCN Dx Clinical Research
DCN Dx, a leading contract research organization for in vitro diagnostics, today acknowledges the FDA’s Emergency Use Authorization (EUA) of the WELLlife™ COVID-19/Influenza A&aB Test, developed by Wondfo USA.
May 15, 2024
·
3 min read
Business
DCN Dx Bolsters Board with Appointment of Former Meridian Biosciences CEO Jack Kenny
DCN Dx, a global leader in the end-to-end development, manufacturing, and commercialization of point-of-use tests, announces the appointment of industry veteran Jack Kenny to its board of directors.
March 12, 2024
·
2 min read
Press Releases
DCN Dx’s Clinical Research Helps Secure FDA Authorization for Cepheid HCV Test
July 10, 2024
·
2 min read
Biotech Beach
DCN Dx and Mapp Biopharmaceutical Announce Subcontract
DCN Dx announced a subcontract with Mapp Biopharmaceutical, Inc., a developer of novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.
February 1, 2023
·
3 min read
Press Releases
Lynx Dx Introduces At-Home Collection Option for MyProstateScore 2.0
February 4, 2025
·
5 min read
Press Releases
IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma
January 23, 2025
·
6 min read
Press Releases
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
January 30, 2025
·
7 min read
BioMed Diagnostics to Attend VMX 2024
BioMed Diagnostics, a leader in microbiological testing and a DCN Dx brand, is pleased to announce their attendance at VMX 2024.
January 9, 2024
·
3 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Business
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States
Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX ® Genomic Test in the United States.
June 18, 2024
·
4 min read
1 of 989
Next
